Body on Chip-A Distant Dream or an Emerging
Reality?
Volume 1 - Issue 4
Benzion Amoyav and Ofra Benny*
-
Author Information
Open or Close
- Faculty of Medicine, The School of Pharmacy, The Institute for Drug Research, The Hebrew University, Campus Ein Karem, Jerusalem, Israel
*Corresponding author:
Ofra Benny, Faculty of Medicine, The School of Pharmacy, The Institute for Drug Research, The Hebrew
University, Campus Ein Karem, 91120 Jerusalem, Israel
Received: May 12, 2018; Published: May 17, 2018
DOI: 10.32474/DDIPIJ.2018.01.000118
Full Text
PDF
To view the Full Article Peer-reviewed Article PDF
Abstract
We are currently facing a global health challenge regarding the
way we discover and develop new drugs. Small biotech companies,
as well as large pharmaceutical corporations, spend increasingly
more money on the classical route of drug development, and it fails
more often than it succeeds. Consequently, some diseases are not
being treated and patients who are in dire need of new therapies
are not receiving them.
Opinion|
Refernces|